BRISTOL MYERS SQUIBB CO (BMY) Factsheet
Earnings-call transcript: none · IR deck: cataloged — watch a real agent read these end-to-end →
BRISTOL MYERS SQUIBB CO (BMY) Stock Analysis
Analysis from 10-Q filed 2026-10-29. Data as of Q3 2026.
Overall Grade: F (Concerning)
Grade F (Concerning). ROIC 14.2%. FCF margin 18.6%. D/E 1.8x. Source: 10-Q filed 2026-10-29.
| Metric | Value | Context |
|---|---|---|
| ROIC | 14.2% | Solid returns |
| FCF Margin | 18.6% | Strong cash generation |
| Debt/Equity | 1.8x | Elevated debt |
ROIC 14.2% — Top 25% of sector peers. FCF margin 18.6% — Top 25%.
Explore BRISTOL MYERS SQUIBB CO: Earnings History | Overview
Programmatic access: Available via MCP at mcp.metricduck.com. Tools for BMY: get_company_overview, get_filing_index (lens: debt_stress, management_outlook, risk_trajectory), get_filing_section, get_metric_history, compare_companies, screen_filing_signals.
Profitability: BRISTOL MYERS SQUIBB CO earns 14.2% ROIC, Top 25% in Healthcare
ROIC TTM 14.2%, sector median -8.0%, Top 25%. DuPont: NOPAT margin 18.5% × asset turnover 0.6x. Gross margin 69.2%. Operating margin 22.6%. Source: 10-Q filed 2026-10-29.
| Metric | BMY | Rating | Context |
|---|---|---|---|
| Return on Invested Capital (ROIC) | 14.2% | Good | Above sector median of -8.0% |
| Return on Equity (ROE) | 45.2% | Excellent | Efficient use of shareholder equity |
| Gross Margin | 69.2% | Excellent | Strong pricing power |
| Operating Margin | 22.6% | Excellent | Efficient operations |
Cash Flow: BRISTOL MYERS SQUIBB CO generates $9.3B FCF at 18.6% margin, positive NaN/8 quarters
FCF TTM $9.3B. FCF margin 18.6%, Top 25%. OCF/Net income 1.2x. Positive FCF in NaN/8 trailing quarters. Source: 10-Q filed 2026-10-29.
| Metric | BMY | Rating | Context |
|---|---|---|---|
| Free Cash Flow Margin | 18.6% | Good | Excellent cash conversion |
| Free Cash Flow (TTM) | $9.3B | Good | Positive cash generation |
| OCF/Net Income | 1.2x | Excellent | High earnings quality |
| FCF Consistency (8Q) | N/A | Warning | Variable cash flow |
Balance Sheet: BRISTOL MYERS SQUIBB CO at 1.8x leverage, 6.9x interest coverage
Debt/Equity 1.8x. Total debt $42.9B, cash & investments $12.6B. Interest coverage 6.9x. Source: 10-Q filed 2026-10-29.
| Metric | BMY | Rating | Context |
|---|---|---|---|
| Debt to Equity | 1.8x | Warning | Elevated leverage |
| Net Cash Position | $-30.3B | Warning | Net debt position |
| Interest Coverage | 6.9x | Good | Comfortable debt service |
Valuation: BRISTOL MYERS SQUIBB CO trades at 13.8x earnings
P/E 13.8x. EV/Sales 3.2x. FCF yield 7.3%. Dividend yield 4.0%. Source: 10-Q filed 2026-10-29.
| Metric | BMY | Rating | Context |
|---|---|---|---|
| P/E Ratio | 13.8x | Adequate | Reasonable valuation |
| EV/Sales | 3.2x | Good | Growth premium priced in |
| FCF Yield | 7.3% | Good | Attractive cash return |
| Dividend Yield | 4.0% | Good | Meaningful income |
Capital Allocation: BRISTOL MYERS SQUIBB CO returns 4.0% shareholder yield
Total shareholder yield 4.0% (div 4.0%). Share count +0.4% YoY. Capital returned $5.1B TTM. Source: 10-Q filed 2026-10-29.
| Metric | BMY | Rating | Context |
|---|---|---|---|
| Total Shareholder Yield | 4.0% | Good | Dividend + buyback yield combined |
| Share Count Change (YoY) | 0.4% | Adequate | Net dilution from issuance/SBC |
| Total Capital Returned (TTM) | $5.1B | Good | Dividends + buybacks returned to shareholders |
Sector Rankings
| Metric | Value | Percentile | vs Median |
|---|---|---|---|
| Return on Invested Capital (ROIC) | 14.2% | Top 25% | - |
| Free Cash Flow Margin | 18.6% | Top 25% | 5.7x above |
| Gross Margin | 69.2% | Top 50% | 1.1x above |
| Operating Margin | 22.6% | Top 25% | - |
| Return on Equity (ROE) | 45.2% | Top 25% | - |
| P/E Ratio | 13.8x | N/A | - |
Financial Scorecard
| Metric | BMY | Rating | Sector Context |
|---|---|---|---|
| Return on Invested Capital (ROIC) | 14.2% | Good | Top 25% of sector (median: -8.0%) |
| Free Cash Flow Margin | 18.6% | Good | Top 25% of sector (median: 3.3%) |
| Gross Margin | 69.2% | Excellent | Top 50% of sector (median: 63.9%) |
| Debt to Equity Ratio | 183.2% | Warning | High financial leverage |
| P/E Ratio (Price-to-Earnings) | 13.8x | Adequate | Attractively valued |
| Free Cash Flow Yield | 7.3% | Good | Solid cash yield |
Frequently Asked Questions
Q: What is BRISTOL MYERS SQUIBB CO's Return on Invested Capital (ROIC)?
BRISTOL MYERS SQUIBB CO (BMY) has a trailing twelve-month Return on Invested Capital (ROIC) of 14.2%. The 8-quarter median ROIC is 13.1% with a improving trend. Sector median -8.0%. Source: 10-Q filed 2026-10-29.
Q: What is BRISTOL MYERS SQUIBB CO's Free Cash Flow Margin?
BRISTOL MYERS SQUIBB CO (BMY) has a free cash flow margin of 18.6%, generating $9.3 billion in free cash flow over the trailing twelve months. Source: 10-Q filed 2026-10-29.
Q: What is BRISTOL MYERS SQUIBB CO's P/E ratio and how does it compare to peers?
BRISTOL MYERS SQUIBB CO (BMY) trades at a P/E ratio of 13.8x, which is above the sector median of N/A. EV/Sales 3.2x. FCF yield 7.3%. Source: 10-Q filed 2026-10-29.
Q: Does BRISTOL MYERS SQUIBB CO pay a dividend?
BRISTOL MYERS SQUIBB CO (BMY) currently pays a dividend yield of 4.0%. Total shareholder yield (dividend + buybacks) 4.0%. Source: 10-Q filed 2026-10-29.
Q: How much debt does BRISTOL MYERS SQUIBB CO have?
BRISTOL MYERS SQUIBB CO (BMY) has a debt-to-equity ratio of 1.8x with total debt of $42.9 billion. Interest coverage 6.9x. Net debt $30.3 billion. Source: 10-Q filed 2026-10-29.
Q: What is BRISTOL MYERS SQUIBB CO's revenue and earnings growth?
BRISTOL MYERS SQUIBB CO (BMY) grew revenue by 4.2% year-over-year. EPS +52.3% YoY. Source: 10-Q filed 2026-10-29.
Q: How does BRISTOL MYERS SQUIBB CO compare to competitors in Healthcare?
Compared to other companies in Healthcare, BRISTOL MYERS SQUIBB CO (BMY) shows: ROIC 14.2%, sector median -8.0% (Top 25%). FCF margin 18.6%, sector median 3.3% (Top 25%). Gross margin 69.2%, 5.4pp above sector median. These rankings are based on MetricDuck's analysis of all Healthcare companies with available SEC filings.
Q: What warning signs should I watch for with BRISTOL MYERS SQUIBB CO?
Quantitative warning flags for BRISTOL MYERS SQUIBB CO (BMY): 1) debt/equity 1.8x (above 1.5x threshold). Source: 10-Q filed 2026-10-29.
Data Source: Data sourced from 10-Q filed 2026-10-29. TTM metrics as of Q3 2026.
Methodology: Financial metrics calculated from SEC 10-K and 10-Q filings using standardized formulas. Sector comparisons use peer group based on SIC code.
Scope: This analysis covers SEC filing fundamentals — profitability, cash flow, balance sheet, and valuation metrics. For analyst estimates and price targets, consult sell-side research.
This analysis is for informational purposes only and does not constitute investment advice.
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms